The Michael Clapcich Fund for Retinal Research is dedicated to promoting research, developing treatments, and providing support for people diagnosed with rare inherited disorders of cobalamin (vitamin B12) transport and metabolism.
Michael's Fund was created by Bob and Josephine Clapcich for their son, Michael, who was diagnosed at birth with Cobalamin Cellular Metabolism Defect Type-C. It is their hope that sight saving research can help Michael and others who suffer from retinal pigmentary degeneration, a major consequence of this rare metabolic defect.